{
    "clinical_study": {
        "@rank": "38369", 
        "acronym": "ERCP", 
        "arm_group": [
            {
                "arm_group_label": "Propofol", 
                "arm_group_type": "Active Comparator", 
                "description": "both midazolam (1mg if aged <= 70 years or 0.5mg in age >70 years) and meperidine 20 mg were given intravenously at the initiation of sedation, Thereafter, an initial bolus of propofol 20 mg intravenously. Sedation was maintained with repeated dose of 5 to 10 mg propofol."
            }, 
            {
                "arm_group_label": "Conventional", 
                "arm_group_type": "Active Comparator", 
                "description": "both midazolam 2 to 5 mg and meperidine 25 to 50 mg were given intravenously at the initiation of sedation. Sedation was maintained with repeated doses of 0.5 to 1.0 mg midazolam and 5 to 10 mg meperidine."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare efficacy and safety of combination of propofol and\n      midazolam with meperidine versus midazolam and meperidine for ambulatory ERCP"
        }, 
        "brief_title": "Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "The propofol was given as initial bolus of 20 mg and then the dose was given 5-10 mg every 30-60 second.the dose of midazolam was 1 mg in patients below 70 years and 0.5 mg in patients \u2265  70 years and the dose of meperidine was fixed at 20 mg.", 
                            "title": "Propofol,Midazolam and Meperidine"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "The initial dose of midazolam and meperidine  were 2-5 mg iv and 25-50 mg iv respectively then the midazolam dose was given 0.5-1.0 mg iv and meperidine dose was given 5-10 mg iv every 2-3 minutes", 
                            "title": "Midazolam and Meperidine"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "140"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "47"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "37"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "84"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "23"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "33"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "56"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "17.35", 
                                                "@value": "55.77"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "16.52", 
                                                "@value": "61.31"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "17.11", 
                                                "@value": "58.54"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "38"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "34"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "72"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "32"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "36"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "68"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "140"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Thailand"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_percent": "95", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Chi-squared", 
                                "non_inferiority": "No", 
                                "p_value": "0.05", 
                                "param_type": "Risk Difference (RD)", 
                                "param_value": "0.2"
                            }
                        }, 
                        "description": "(1) desaturation(oxygen saturation < 90 % at least 10 second ) (2) hypotension ( systolic blood pressure < 90 mmHg or dropped more than 25 % of baseline ) (3)bradycardia (heart rate < 50 beats/min) and (4) apnea ( cessation of respiratory activity for over 10 seconds ). When patients developed oxygen saturation < 90 %, then nasal oxygen was administered, If patients not able to recover from oxygen therapy and tactile stimulations thus the procedure was terminated. The procedure was terminated if patients developed serious adverse event as heart rate below 5 beats/min and or apnea.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "the dose of midazolam was 1 mg in patients below 70 years and 0.5 mg in patients \u2265 70 years and the dose of meperidine was fixed at 20 mg. The propofol was given as initial bolus of 20 mg and then the dose was given 5-10 mg every 30-60 second to maintained the desired level of sedation(moderate to deep sedation ) without maximum limit.", 
                                    "title": "Propofol,Midazolam and Meperidine"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "the initial dose of midazolam and meperidine were 2-5 mg iv and 25-50 mg iv respectively then the midazolam dose was given 0.5-1.0 mg iv and meperidine dose was given 5-10 mg iv every 2-3 minutes to maintain the desired level of sedation(moderate to deep sedation ) without maximum limit.", 
                                    "title": "Midazolam and Meperidine"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "26"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "40"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Participants with desatuartion"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "14"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Participants with hypotension"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Participants with bradycardia"
                                            }
                                        ]
                                    }, 
                                    "description": "(1) desaturation(oxygen saturation < 90 % at least 10 second ) (2) hypotension ( systolic blood pressure < 90 mmHg or dropped more than 25 % of baseline ) (3)bradycardia (heart rate < 50 beats/min) and (4) apnea ( cessation of respiratory activity for over 10 seconds ). When patients developed oxygen saturation < 90 %, then nasal oxygen was administered, If patients not able to recover from oxygen therapy and tactile stimulations thus the procedure was terminated. The procedure was terminated if patients developed serious adverse event as heart rate below 5 beats/min and or apnea.", 
                                    "param": "Number", 
                                    "title": "Cardiovascular Adverse Events.", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Intention to treat population include participants who received sedative agents and underwent ERCP.", 
                        "safety_issue": "Yes", 
                        "time_frame": "participants will be followed for the duration of procedure, an expected average of 2.0 hours", 
                        "title": "Cardiovascular Adverse Events.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 2 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.05", 
                                "param_type": "Mean Difference (Final Values)", 
                                "param_value": "28"
                            }
                        }, 
                        "description": "(1) induction time ( the time from sedation to scope intubation ), (2) procedure time ( the time from scope intubation to scope withdrawal ) and (3) recovery time ( the time from scope withdrawal to full recovery ).The induction time, procedural time and recovery time were recorded by the nurse in the endoscopy unit.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "the dose of midazolam was 1 mg in patients below 70 years and 0.5 mg in patients \u2265 70 years and the dose of meperidine was fixed at 20 mg. The propofol was given as initial bolus of 20 mg and then the dose was given 5-10 mg every 30-60 second to maintained the desired level of sedation (moderate to deep sedation ) without maximum limit", 
                                    "title": "Propofol,Midazolam and Meperidine"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "the initial dose of midazolam and meperidine were 2-5 mg iv and 25-50 mg iv respectively then the midazolam dose was given 0.5-1.0 mg iv and meperidine dose was given 5-10 mg iv every 2-3minutes to maintain the desired level of sedation (moderate to deep sedation ) without maximum limit.", 
                                    "title": "Midazolam and Meperidine"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "27.50", 
                                                            "@value": "40.67"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "31.35", 
                                                            "@value": "43.24"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "procedure time"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "2.18", 
                                                            "@value": "3.94"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.51", 
                                                            "@value": "5.47"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "induction time"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "23.03", 
                                                            "@value": "24.71"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "54.62", 
                                                            "@value": "88.50"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "recovery time"
                                            }
                                        ]
                                    }, 
                                    "description": "(1) induction time ( the time from sedation to scope intubation ), (2) procedure time ( the time from scope intubation to scope withdrawal ) and (3) recovery time ( the time from scope withdrawal to full recovery ).The induction time, procedural time and recovery time were recorded by the nurse in the endoscopy unit.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Procedure Related Time", 
                                    "units": "minutes"
                                }
                            ]
                        }, 
                        "population": "Intention to treat population include participants who received sedative agents and underwent endoscopic retrograde cholangiopancreatography(ERCP).", 
                        "safety_issue": "No", 
                        "time_frame": "participants will be followed for the duration of procedure, an expected average of 2.0 hours ]", 
                        "title": "Procedure Related Time", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "The propofol was given as initial bolus of 20 mg and then the dose was given 5-10 mg every 30-60 second.the dose of midazolam was 1 mg in patients below 70 years and 0.5 mg in patients \u2265  70 years and the dose of meperidine was fixed at 20 mg.", 
                            "title": "Propofol"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "The initial dose of midazolam and meperidine  were 2-5 mg iv and 25-50 mg iv respectively then the midazolam dose was given 0.5-1.0 mg iv and meperidine dose was given 5-10 mg iv every 2-3 minutes", 
                            "title": "Conventional"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "70", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "70", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "70", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "70", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Patients were excluded from the final analysis  if the procedure was terminated due to technical reasons prior to attempted cannulation.", 
                "recruitment_details": "Patients who were schedule for endoscopic retrograde cholangiopancreatography in NKC Institute ,Prince of Songkla University during January 2010-December 2011"
            }, 
            "point_of_contact": {
                "email": "nisasan@yahoo.com", 
                "name_or_title": "Dr. Nisa Netinatsunton", 
                "organization": "Prince of Songkhla University", 
                "phone": "6674451965 ext 9"
            }, 
            "reported_events": {
                "desc": "ERCP complications and sedation related complications are assessed one month after the procedure date.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "The propofol was given as initial bolus of 20 mg and then the dose was given 5-10 mg every 30-60 second.the dose of midazolam was 1 mg in patients below 70 years and 0.5 mg in patients \u2265  70 years and the dose of meperidine was fixed at 20 mg.", 
                            "title": "Propofol,Midazolam and Meperidine"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "The initial dose of midazolam and meperidine  were 2-5 mg iv and 25-50 mg iv respectively then the midazolam dose was given 0.5-1.0 mg iv and meperidine dose was given 5-10 mg iv every 2-3 minutes", 
                            "title": "Midazolam and Meperidine"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "26", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "40", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "26", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "26", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@events": "40", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "40", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Hypoxia"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "ERCP complications", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Severe bradycardia"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "ERCP complications"
                }, 
                "time_frame": "1 month"
            }
        }, 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Disorders of Gallbladder, Biliary Tract and Pancrease", 
        "condition_browse": {
            "mesh_term": "Gallbladder Diseases"
        }, 
        "detailed_description": {
            "textblock": "ERCP is commonly done under sedation with midazolam and meperidine, however some studies\n      showed varying outcomes of this conventional sedation for maintained sedation. Propofol is\n      increasing used for sedation in gastrointestinal procedure owing to its rapid recovery\n      profiles but the  complications associated with propofol are not negligible.The\n      investigators prospectively compare the efficacy, induction time, recovery time, patient\n      satisfaction and side effect between propofol based and conventional sedations in patients\n      undergoing ERCP."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        . All outpatients aged more than 18 years who were schedule for ERCP  -\n\n        Exclusion Criteria:\n\n          -  pregnant  woman\n\n          -  emergency situation ( i.e. concomitant upper gastrointestinal bleeding, acute\n             cholangitis )\n\n          -  American Society of Anesthesiologist ( ASA )Class IV or V\n\n          -  respiratory disease,\n\n          -  sleep apnea\n\n          -  allergy to egg or soybean\n\n          -  drug abuse( benzodiazepine, opioid agonist )\n\n          -  previous history of failure sedation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 27, 2012", 
        "firstreceived_results_date": "November 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01709422", 
            "org_study_id": "1774906506805161"
        }, 
        "intervention": [
            {
                "arm_group_label": "Propofol", 
                "description": "Propofol is the  sedative drug used as an  additional sedation to one of the study arm.", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug", 
                "other_name": "Diprivan"
            }, 
            {
                "arm_group_label": [
                    "Propofol", 
                    "Conventional"
                ], 
                "description": "Midazolam is one of the two conventional sedative drugs included in both arms.", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug", 
                "other_name": "Benzodiazepine"
            }, 
            {
                "arm_group_label": [
                    "Propofol", 
                    "Conventional"
                ], 
                "description": "Meperidine is one of the two conventional sedative drugs included in both arms.", 
                "intervention_name": "Meperidine", 
                "intervention_type": "Drug", 
                "other_name": "Pethidine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Meperidine", 
                "Midazolam", 
                "Propofol"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Propofol", 
            "Midazolam", 
            "Meperidine"
        ], 
        "lastchanged_date": "September 12, 2013", 
        "link": {
            "description": "Prince of Songkhla University", 
            "url": "http://www.nkc-psu.org"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Hatyai", 
                    "country": "Thailand", 
                    "state": "Songkhla", 
                    "zip": "90110"
                }, 
                "name": "NKC Institues of Gastroenterology and Hepatology, Prince of Songkla University"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety Profiles of Sedation With Propofol Combined With Intravenous Midazolam and Meperidine Versus Intravenous Midazolam and Meperidine for Ambulatory Endoscopic Retrograde-cholangiopancreatography(ERCP).", 
        "overall_official": [
            {
                "affiliation": "NKC Institute of Gastroenterology and Hepatology, Prince of Songklanakarind University", 
                "last_name": "Nisa Netinatsunton, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Prince of Songkla University", 
                "last_name": "Nisa Netinatsunton, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "(1) induction time ( the time from sedation to scope intubation ), (2) procedure time ( the time from scope intubation to scope withdrawal ) and (3) recovery time ( the time from scope withdrawal to full recovery ).The induction time, procedural time and recovery time were recorded by the nurse in the endoscopy unit.", 
            "measure": "Procedure Related Time", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for the duration of procedure, an expected average of 2.0 hours ]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01709422"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Prince of Songkla University", 
            "investigator_full_name": "Nisa Netinatsunton", 
            "investigator_title": "NKC Institute of Gastroenterology and Hepatology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "(1) desaturation(oxygen saturation < 90 % at least 10 second ) (2) hypotension ( systolic blood pressure < 90 mmHg or dropped more than 25 % of baseline ) (3)bradycardia (heart rate < 50 beats/min) and (4) apnea ( cessation of respiratory activity for over 10 seconds ). When patients developed oxygen saturation < 90 %, then nasal oxygen was administered, If patients not able to recover from oxygen therapy and tactile stimulations thus the procedure was terminated. The procedure was terminated if patients developed serious adverse event as heart rate below 5 beats/min and or apnea.", 
            "measure": "Cardiovascular Adverse Events.", 
            "safety_issue": "Yes", 
            "time_frame": "participants will be followed for the duration of procedure, an expected average of 2.0 hours"
        }, 
        "source": "Prince of Songkla University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Prince of Songkla University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}